Krishnagiri, India

Soodamani Thangavel


 

Average Co-Inventor Count = 9.9

ph-index = 2

Forward Citations = 26(Granted Patents)


Location History:

  • Hosur, IN (2019 - 2020)
  • Krishnagiri, IN (2017 - 2024)
  • Bengaluru, IN (2024)

Company Filing History:


Years Active: 2017-2025

Loading Chart...
Loading Chart...
13 patents (USPTO):Explore Patents

Title: Soodamani Thangavel: Innovator in Pharmaceutical Compounds

Introduction

Soodamani Thangavel is a prominent inventor based in Krishnagiri, India, known for his significant contributions to the field of pharmaceuticals. With a total of 13 patents to his name, he has made remarkable advancements in the development of compounds that target various health conditions.

Latest Patents

Among his latest patents is a groundbreaking invention related to substituted amide compounds that serve as farnesoid X receptor modulators. This patent discloses compounds that can modulate the activity of the farnesoid X receptor (FXR), which is crucial in treating diseases associated with FXR dysregulation, such as pathological fibrosis, transplant rejection, cancer, osteoporosis, and inflammatory disorders. Another notable patent involves inhibitors of indoleamine 2,3-dioxygenase (IDO), which are designed to treat proliferative disorders, including cancer and autoimmune diseases.

Career Highlights

Soodamani has worked with esteemed companies such as Bristol-Myers Squibb Company and Syngene International Limited. His experience in these organizations has allowed him to refine his expertise in pharmaceutical research and development.

Collaborations

Throughout his career, Soodamani has collaborated with notable colleagues, including Susheel Jethanand Nara and Srinivas Cheruku. These partnerships have contributed to the success of his innovative projects.

Conclusion

Soodamani Thangavel's work in developing pharmaceutical compounds has made a significant impact on the medical field. His inventions continue to pave the way for new treatments and therapies that address critical health issues.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…